EU to okay deal with CureVac for supply of up to 405 mln COVID vaccines

BRUSSELS, Nov 16 (Reuters) - The European Commission will authorise on Tuesday a deal with biotech firm CureVac to secure up to 405 million doses of its potential COVID-19 vaccine, the head of the European Commission Ursula von der Leyen said on Monday.

The Commission president also said she hopes to finalise a deal soon with Moderna for its COVID-19 vaccine. (Reporting by Francesco Guarascio @fraguarascio)


Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.

Sign up for a free trial of our full service at and follow us on Twitter @Breakingviews and at All opinions expressed are those of the authors.